This Solicitation opportunity from Government of Canada was posted on January 31, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
RFP - Manufacture and Supply of Buffered Diluent containing Glycerol and Sterile Empty Vials with Cap Enclosure
Closed
WS4617512505CanadaSubmission Closed
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
General Info
Agency
Government of Canada → Department of Public Works and Government ServicesView Agency
NAICS
N/A
Place of Performance
*National Capital Region (NCR), CANSet-Aside
NONE
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
1 update
PhaseClosed
Submission Closed
Organization & Contact Information
Show more
AgencyGovernment of Canada → Department of Public Works and Government Services
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Department of Public Works and Government Services
View Agency ProfileOffice AddressN/A
Contacts
Full Description
Show more
Canada must procure and maintain a stockpile of medical countermeasures (MCM), including diluent and sterile empty glass vials required for vaccination, to support response to Canadian public health emergencies and events.
The Government of Canada has a requirement for the services of a Contractor to manufacture and supply 73,500 vials of a sterile 0.2% phenol, phosphate-citrate based buffered diluent containing 45% glycerol (pH 7.4) in 2 mL labelled vials, accompanied by 11,000 empty 2mL labelled sterile glass vials with a removable cap enclosure system capable of being re-stoppered, in accordance with the technical specifications set out in Appendix A of this solicitation. The diluent and empty vials must be manufactured in accordance with Canada’s Food and Drug Regulations, Part C, Division 2 - current Good Manufacturing Practices (GMP), and be of sufficient quality for use in humans.